| MeSH term | MeSH ID | Detail |
|---|---|---|
| Osteolysis, Essential | D010015 | 1 associated lipids |
| Osteoporotic Fractures | D058866 | 1 associated lipids |
| Hemangioma, Capillary | D018324 | 1 associated lipids |
| Dentin Dysplasia | D003805 | 1 associated lipids |
| Neoplasms, Squamous Cell | D018307 | 1 associated lipids |
| Cleidocranial Dysplasia | D002973 | 1 associated lipids |
| Prediabetic State | D011236 | 1 associated lipids |
| Intracranial Hemorrhage, Traumatic | D020198 | 1 associated lipids |
| Neoplastic Syndromes, Hereditary | D009386 | 1 associated lipids |
| Scleroderma, Limited | D045745 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lis GJ et al. | Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. | 2016 | Pol. Arch. Med. Wewn. | pmid:27003233 |
| Tsuruda T et al. | Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. | 2016 | Hypertension | pmid:27001297 |
| Kats A et al. | Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. | 2016 | J. Cell. Mol. Med. | pmid:26987561 |
| Moran CS et al. | Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. | 2016 | Arterioscler. Thromb. Vasc. Biol. | pmid:26966276 |
| Cong Q et al. | p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. | 2016 | Stem Cell Reports | pmid:26947973 |
| Wang C et al. | Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. | 2016 | Med. Sci. Monit. | pmid:26939934 |
| Lin J et al. | Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. | 2016 | Nat Commun | pmid:26923114 |
| Li N et al. | Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. | 2016 | Pharmazie | pmid:29441931 |
| Alam I et al. | Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. | 2016 | Endocrinology | pmid:26584014 |
| Zhao N et al. | Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. | 2016 | J. Bone Miner. Res. | pmid:26274352 |
| Liu YD et al. | Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. | 2016 | Osteoarthr. Cartil. | pmid:26256766 |
| Liu G et al. | Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. | 2016 | Cell Tissue Res. | pmid:26004143 |
| Wang S et al. | Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. | 2016 | J Ethnopharmacol | pmid:27109342 |
| Bergamini A et al. | Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. | 2016 | Int J Med Sci | pmid:28090190 |
| Toffoli B et al. | Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. | 2016 | Mediators Inflamm. | pmid:28070143 |
| Xing R et al. | Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. | 2016 | Int. J. Mol. Med. | pmid:27599586 |
| Yongdi L et al. | [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27526445 |
| Qian H et al. | FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. | 2016 | Mol Med Rep | pmid:27510616 |
| Røysland R et al. | Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. | 2016 | PLoS ONE | pmid:27463973 |
| Piemontese M et al. | Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27460899 |
| Zhao JJ et al. | MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. | 2016 | PLoS ONE | pmid:27459539 |
| Ugay L et al. | Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. | 2016 | Chin. Med. J. | pmid:27411457 |
| Pellegrini GG et al. | Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. | 2016 | Nutrients | pmid:27409635 |
| Sasso GR et al. | Elevated serum osteoprotegerin levels in women: friend or foe? | 2015 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:26841162 |
| Calasans-Maia MD et al. | Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814461 |
| Jianru YI et al. | Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814456 |
| SaÄŸlam M et al. | Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. | 2015 Jan-Feb | J Appl Oral Sci | pmid:25760266 |
| Esteghamati A et al. | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. | 2015 Aug-Sep | Arch Cardiovasc Dis | pmid:26184866 |
| Verde ME et al. | Effect of Bisphosphonates on the Levels of Rankl and Opg in Gingival Crevicular Fluid of Patients With Periodontal Disease and Post-menopausal Osteoporosis. | 2015 | Acta Odontol Latinoam | pmid:27095621 |
| Li G et al. | Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. | 2015 | Int J Clin Exp Pathol | pmid:26884838 |
| Li B et al. | Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. | 2015 | Genet. Mol. Res. | pmid:26782591 |
| Zang L et al. | The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis. | 2015 | Sci Rep | pmid:26671549 |
| Liu W et al. | Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. | 2015 | PLoS ONE | pmid:26571489 |
| Schiro A et al. | Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. | 2015 | Sci Rep | pmid:26564003 |
| Mizuno M et al. | Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. | 2015 | Sci Rep | pmid:26561427 |
| Morisawa T et al. | Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. | 2015 | Int Heart J | pmid:26549398 |
| Beuselinck B et al. | RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. | 2015 | Br. J. Cancer | pmid:26528707 |
| Rewiuk K and Grodzicki T | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. | 2015 | Biomed Res Int | pmid:26504794 |
| Pesce Viglietti AI et al. | Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. | 2015 | Infect. Immun. | pmid:26459511 |
| Nemeth ZK et al. | Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. | 2015 | Sci Rep | pmid:26459001 |
| Zhang HL and Jin X | Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity. | 2015 | Genet. Mol. Res. | pmid:26400332 |
| Ren H et al. | Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. | 2015 | Mol Med Rep | pmid:26398911 |
| Board-Davies E et al. | Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin. | 2015 | Stem Cells Transl Med | pmid:26378260 |
| Kato G et al. | The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. | 2015 | Arthritis Res. Ther. | pmid:26373710 |
| Li CW et al. | Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. | 2015 | Genet. Mol. Res. | pmid:26345854 |
| Pan X et al. | Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. | 2015 | PLoS ONE | pmid:26334877 |
| Audo R et al. | Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. | 2015 | Arthritis Res. Ther. | pmid:26220665 |
| Wang J et al. | RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. | 2015 | PLoS ONE | pmid:26218592 |
| Kao SY and Stankovic KM | Transactivation of human osteoprotegerin promoter by GATA-3. | 2015 | Sci Rep | pmid:26216189 |
| Kassem A et al. | TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. | 2015 | FASEB J. | pmid:26207027 |
| Yang H et al. | A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. | 2015 | Int J Clin Exp Pathol | pmid:26191212 |
| Pitari MR et al. | Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. | 2015 | Oncotarget | pmid:26160841 |
| Hsu BG et al. | High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. | 2015 | Tohoku J. Exp. Med. | pmid:26156285 |
| Miao X et al. | Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. | 2015 | J Orthop Surg Res | pmid:26148858 |
| Fernández-González FJ et al. | Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. | 2015 | Dental Press J Orthod | pmid:26560822 |
| Bartosińska J et al. | The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. | 2015 | Mediators Inflamm. | pmid:26146462 |
| Ye XH et al. | Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. | 2015 | Genet. Mol. Res. | pmid:26125863 |
| Yu SG et al. | Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. | 2015 | Int J Clin Exp Pathol | pmid:26097549 |
| Schmitz F et al. | Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. | 2015 | Cell Metab. | pmid:26094892 |
| Kondegowda NG et al. | Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. | 2015 | Cell Metab. | pmid:26094891 |
| Telejko B et al. | The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. | 2015 | Ann Agric Environ Med | pmid:26094529 |
| Ketlogetswe KS et al. | Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. | 2015 | J. Acquir. Immune Defic. Syndr. | pmid:26090754 |
| Burton LJ et al. | Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. | 2015 | Carcinogenesis | pmid:26069256 |
| Ye M et al. | Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. | 2015 | Mol Med Rep | pmid:26459042 |
| Yang Y et al. | The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. | 2015 | J. Biol. Chem. | pmid:25979341 |
| Ehlken C et al. | Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. | 2015 | PLoS ONE | pmid:25978399 |
| Ardeshirpour L et al. | OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. | 2015 | Endocrinology | pmid:25961842 |
| Reveille JD | Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. | 2015 | Clin. Rheumatol. | pmid:25939520 |
| Bortolin RH et al. | Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. | 2015 | PLoS ONE | pmid:25933189 |
| Wei J et al. | Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. | 2015 | Mol Med Rep | pmid:25891179 |
| Su F et al. | Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. | 2015 | Stem Cell Res Ther | pmid:25888745 |
| Shen Y et al. | (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. | 2015 | BMC Complement Altern Med | pmid:25887296 |
| Duan P et al. | Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. | 2015 | BMC Womens Health | pmid:25884698 |
| Warren JT et al. | Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. | 2015 | J. Cell. Biochem. | pmid:25864714 |
| Kim KR et al. | 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. | 2015 | PLoS ONE | pmid:25859665 |
| Wu C et al. | Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. | 2015 | Genes Dev. | pmid:25846796 |
| Åšwierkot J et al. | Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. | 2015 | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:25837853 |
| Hassan SH et al. | Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. | 2015 | Dis. Markers | pmid:25814780 |
| Folestad A et al. | Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. | 2015 | Acta Orthop | pmid:25811776 |
| Sutton KM et al. | The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. | 2015 | Dev. Comp. Immunol. | pmid:25796577 |
| Zheng Y et al. | Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. | 2015 | J. Dent. Res. | pmid:25762594 |
| Tsuruda T | Osteoprotegerin: osteo-vascular connection. | 2015 | J. Atheroscler. Thromb. | pmid:25740050 |
| Higgs JT et al. | Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. | 2015 | Mol. Cancer Res. | pmid:25636966 |
| Lanza D et al. | Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. | 2015 | PLoS ONE | pmid:25635832 |
| Dale MD et al. | Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. | 2015 | Int J Mol Sci | pmid:25625518 |
| Ottewell PD et al. | OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. | 2015 | Int. J. Cancer | pmid:25603921 |
| Son GY et al. | Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. | 2015 | J. Dent. Res. | pmid:25595364 |
| Oostra DR et al. | Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. | 2015 | Mol. Cell. Endocrinol. | pmid:25575458 |
| Majerczyk M et al. | [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. | 2015 | Postepy Hig Med Dosw (Online) | pmid:27259222 |
| Fu Y et al. | Involvement of the Ca²⺠signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. | 2015 | J. Vet. Sci. | pmid:25549213 |
| Lin TH et al. | NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. | 2015 | Tissue Eng Part A | pmid:25518013 |
| Kadlub N et al. | The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. | 2015 | J. Bone Miner. Res. | pmid:25491283 |
| Rao M et al. | Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice. | 2015 | Exp. Hematol. | pmid:25461255 |
| Estanislau IM et al. | Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. | 2015 | Br J Clin Pharmacol | pmid:25444240 |
| Recker EN et al. | A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. | 2015 | J. Periodontol. | pmid:25269523 |
| Meijome TE et al. | GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. | 2015 | J. Cell. Physiol. | pmid:25205203 |
| Solberg LB et al. | Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes. | 2015 | Histochem. Cell Biol. | pmid:25201349 |
| Hung JY et al. | Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. | 2015 | Int. J. Oncol. | pmid:25738754 |
| Nash LA et al. | Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. | 2015 | Mol Nutr Food Res | pmid:25488131 |
| Jin Y et al. | Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. | 2015 | Angle Orthod | pmid:24810489 |